Cargando…
Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with a continuously growing prevalence. The pathophysiology of the disease is complex and includes several mechanisms, with metabolic syndrome and insulin resistance playing a major role. It is crucial to diagnose...
Autores principales: | Bassal, Tamara, Basheer, Maamoun, Boulos, Mariana, Assy, Nimer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692389/ https://www.ncbi.nlm.nih.gov/pubmed/36355154 http://dx.doi.org/10.3390/metabo12111073 |
Ejemplares similares
-
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023) -
Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against?
por: Basheer, Maamoun, et al.
Publicado: (2022) -
Liver Fat Storage Is a Better Predictor of Coronary Artery Disease than Visceral Fat
por: Basheer, Maamoun, et al.
Publicado: (2023) -
Increased Red Blood Cell Distribution Predicts Severity of Chronic Obstructive Pulmonary Disease Exacerbation
por: Saad, Elias, et al.
Publicado: (2023) -
Clinical Predictors of Mortality and Critical Illness in Patients with COVID-19 Pneumonia
por: Basheer, Maamoun, et al.
Publicado: (2021)